Occupational Hand Dermatitis in 164 Taipei Clinic Patients

November 12, 2026

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.

Reader question: How were irritant and allergic diagnoses distributed among 164 Taipei occupational hand-dermatitis patients?

Study snapshot

Study element	Reported detail
Population	164 patients diagnosed with occupational hand dermatitis in a tertiary contact-dermatitis referral clinic in Taipei.
Design	Clinic interview, examination and European standard plus suspected-allergen patch testing, with logistic modeling of allergic versus irritant presentations.
Comparator	Allergic and irritant occupational hand-dermatitis groups were compared by site, atopy and clinical presentation.
Timepoint	One referral evaluation; no prospective follow-up.
Key result	Occupational hand dermatitis accounted for 36% of clinic patients. Among 164 cases, 58.5% were classified as irritant and 41.5% as allergic; atopic history and palm involvement favored irritant classification, while nail-fold involvement favored allergic disease.
Funding/conflict context	The indexed abstract does not state funding or conflicts. No moisturizer was evaluated.

What was actually measured?

Occupational hand dermatitis accounted for 36% of clinic patients. Among 164 cases, 58.5% were classified as irritant and 41.5% as allergic; atopic history and palm involvement favored irritant classification, while nail-fold involvement favored allergic disease.

The study shows how distribution and history informed differential diagnosis, while patch-test positivity still required exposure relevance.

The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.

What the result does not prove

Tertiary referral selection, historical products and practices, single-center diagnosis and no external validation limit prevalence and prediction claims.

Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.

A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.

Exposure detail matters more than the job label

Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.

A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.

Questions worth recording

Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
Where did the change begin, and did it improve on days away or after a process or PPE change?
How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
Were labels, ingredient information and safety-data sheets reviewed with occupational health?
Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?

Prevention comes before cosmetic care

Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.

Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.

Primary research and guidance

Where Dr. Arsy #003 fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.

Continue the evidence series

Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.

← Back to Doctor's Notes